Details for Patent: 9,351,923

Which drugs does patent 9,351,923 protect, and when does it expire?

Patent 9,351,923 protects SIGNIFOR LAR KIT and is included in one NDA.

This patent has forty-nine patent family members in forty-one countries.

Summary for Patent: 9,351,923

Title:	Extended-release composition comprising a somatostatin derivative in microparticles
Abstract:	The present invention relates to improved microparticles comprising a somatostatin analog, a process of making said microparticles and to pharmaceutical compositions comprising the same.
Inventor(s):	Lambert; Olivier (Spechbach le Haut, FR), Riemenschnitter; Marc (Freiburg, DE), Vucenovic; Vitomir (Loerrach, DE)
Assignee:	Novartis AG (Basel, CH)
Application Number:	13/743,385
Patent Claim Types: see list of patent claims	Composition; Formulation; Compound; Process;

Drugs Protected by US Patent 9,351,923

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Recordati Rare	SIGNIFOR LAR KIT	pasireotide pamoate	FOR SUSPENSION;INTRAMUSCULAR	203255-004	Jun 29, 2018		RX	Yes	No			Y
Recordati Rare	SIGNIFOR LAR KIT	pasireotide pamoate	FOR SUSPENSION;INTRAMUSCULAR	203255-001	Dec 15, 2014		RX	Yes	No			Y
Recordati Rare	SIGNIFOR LAR KIT	pasireotide pamoate	FOR SUSPENSION;INTRAMUSCULAR	203255-005	Jun 29, 2018		RX	Yes	No			Y

Foreign Priority and PCT Information for Patent: 9,351,923

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	07108796	May 24, 2007

International Family Members for US Patent 9,351,923

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	066677
Australia	2008252931
Brazil	PI0811904